{"nct_id":"NCT01220570","title":"The Growth Factor Signature (GFS) as an Intermediate Biomarker of Response for Development of PI3K-Pathway Inhibitors in Patients With Breast Cancer (MK-8669-050)","status":"COMPLETED","status_verified_date":"2015-01","start_date":"2010-09","start_date_type":null,"primary_completion_date":"2012-12","primary_completion_date_type":"ACTUAL","completion_date":"2012-12","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}